Skip to main content
. 2022 Jan 27;13:834851. doi: 10.3389/fimmu.2022.834851

Table 3.

Type of respiratory support (oxygen therapy and invasive ventilation), ICU admission, and clinical outcomes (ARDS, severe COVID-19, and in-hospital mortality) of patients 50 years and over, stratified by sex (if data are known on a subset of patients, the number is indicated in parenthesis after the variable name).

Outcome, n (%) Overall n=120 (%) Sex P-value
Female n=52 (%) Male n=68 (%)
Type of treatment
Any oxygen therapy
 NO 24 (20.0) 14 (26.9) 10 (14.7) 0.0973
 YES 96 (80.0) 38 (73.1) 58 (85.3)
Invasive ventilation
 NO 112 (93.3) 52 (100.0) 60 (88.2) 0.0097
 YES 8 (6.7) 0 (0.0) 8 (11.8)
ICU admission
 NO 108 (90) 52 (100.0) 56 (82.4) 0.0023
 YES 12* (10) 0 (0.0) 12 (17.7)
ARDS (119/120)
 NO 66 (55.5) 34 (65.4) 32 (47.8) 0.0550
 YES 53 (44.5) 18 (34.6) 35 (52.2)
ARDS severity (117/120)
 No ARDS 66 (56.4) 34 (68.0) 32 (47.8) 0.0107
 Mild ARDS 20 (17.1) 10 (20.0) 10 (14.9)
 Moderate ARDS 9 (7.7) 3 (6.0) 6 (9.0)
 Severe ARDS 22 (18.8) 3 (6.0) 19 (28.4)
Severe COVID-19
 NO 23 (19.2) 11 (21.1) 12 (17.6) 0.6287
 YES 97 (80.8) 41 (78.9) 56 (82.4)
In-hospital mortality
 NO 92 (76.7) 39 (75.0) 53 (77.9) 0.7058
 YES 28 (23.3) 13 (25.0) 15 (22.1)

*median ICU staying duration is equal to 8.5 days [IQR 5.75, 13.5].